Sean Platt, MD
Retina Specialist · Beachwood, OHNPI 1518252915
Payments from drug & device makers
Across 336 payments — averaging $125.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ANI Pharmaceuticals, Inc.$19K
- AbbVie$6K
- Genentech USA, Inc.$6K
- Alimera Sciences, Inc.$4K
- Regeneron Healthcare Solutions, Inc.$2K
- Genentech, Inc.$1K
- plus $4K from 20 others
Across 15 payments — averaging $3918.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alimera Sciences, Inc.$57K
- Regeneron$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 11 | $19,334 |
| AbbVie(2 entities) | 40 | $6,472 |
| Genentech USA, Inc. | 49 | $5,782 |
| Alimera Sciences, Inc. | 51 | $3,975 |
| Regeneron Healthcare Solutions, Inc. | 74 | $1,719 |
| Genentech, Inc. | 6 | $1,123 |
| Dutch Ophthalmic, USA | 8 | $934 |
| Apellis Pharmaceuticals, Inc. | 32 | $792 |
| Novartis | 11 | $336 |
| Alcon | 3 | $316 |
| Astellas Pharma US Inc | 10 | $299 |
| Coherus Oncology, Inc. | 3 | $183 |
| Bausch & Lomb Americas Inc. | 5 | $174 |
| Ocular Therapeutix, Inc. | 1 | $146 |
| Eyepoint US, Inc. | 7 | $146 |
| Zimmer Biomet | 4 | $146 |
| Mallinckrodt Hospital Products Inc. | 5 | $130 |
| Neurotech Pharmaceuticals, Inc. | 4 | $89 |
| Harrow Eye, LLC | 2 | $73 |
| Kala Pharmaceuticals, Inc. | 3 | $38 |
| Sandoz | 1 | $31 |
| Carl Zeiss Meditec, Inc. | 2 | $28 |
| Vantage Technology LLC | 1 | $26 |
| Omeros Corporation | 1 | $14 |
| Sun Pharmaceutical Industries Inc. | 1 | $11 |
| Notal Vision, Inc. | 1 | $10 |
How this compares
$42,330 in reported general payments places this provider in the 70th percentile of 69 retina specialist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Beachwood
- Joseph ConeyBeachwood$2.1M
- Llewelyn RaoBeachwood$718K
- David MillerBeachwood$299K
- Michael NovakBeachwood$71K
- Scott PendergastBeachwood$66K
- Jerome SchartmanBeachwood$49K
- Lediana GoduniBeachwood$9K
- Shawn LewisBeachwood$7K
- David ShiehBeachwood$3K
- Hernando ZegarraBeachwood$478
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.